These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10566040)

  • 1. Etanercept. Soluble tumour necrosis factor receptor, TNF receptor fusion protein, TNFR-Fc, TNR 001, Enbrel.
    Drugs R D; 1999 Mar; 1(3):258-61. PubMed ID: 10566040
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept. Soluble tumour necrosis factor receptor, TNF receptor fusion protein, TNFR-Fc, TNR 001, Enbrel.
    Drugs R D; 1999 Jan; 1(1):75-7. PubMed ID: 10565993
    [No Abstract]   [Full Text] [Related]  

  • 3. CDP 571. Anti-TNF monoclonal antibody, BAY 103356.
    Drugs R D; 1999 Mar; 1(3):253-5. PubMed ID: 10566038
    [No Abstract]   [Full Text] [Related]  

  • 4. ISIS 2302. Oligo-TCS.
    Drugs R D; 1999 Mar; 1(3):265-7. PubMed ID: 10566042
    [No Abstract]   [Full Text] [Related]  

  • 5. Ridogrel. R 68070.
    Drugs R D; 1999 Mar; 1(3):270-2. PubMed ID: 10566044
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin-10. Cytokine synthesis inhibitory factor, SCH 52000, rIL-10, rhIL-10.
    Drugs R D; 1999 Mar; 1(3):262-4. PubMed ID: 10566041
    [No Abstract]   [Full Text] [Related]  

  • 7. Etanercept for Crohn's disease.
    Travers SB
    N Engl J Med; 2004 Feb; 350(8):840; author reply 840. PubMed ID: 14973205
    [No Abstract]   [Full Text] [Related]  

  • 8. Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment.
    Tsimberidou AM; Waddelow T; Kantarjian HM; Albitar M; Giles FJ
    Leuk Res; 2003 May; 27(5):375-80. PubMed ID: 12620287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept).
    Yazisiz V; Avci AB; Erbasan F; Yildirim B; Terzioğlu E
    Colorectal Dis; 2008 Nov; 10(9):953-4. PubMed ID: 18294265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.
    Mitoma H; Horiuchi T; Tsukamoto H; Ueda N
    Cytokine; 2018 Jan; 101():56-63. PubMed ID: 27567553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis.
    Murray KM; Dahl SL
    Ann Pharmacother; 1997 Nov; 31(11):1335-8. PubMed ID: 9391689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome.
    Maciejewski JP; Risitano AM; Sloand EM; Wisch L; Geller N; Barrett JA; Young NS
    Br J Haematol; 2002 Apr; 117(1):119-26. PubMed ID: 11918541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives.
    Blam ME; Stein RB; Lichtenstein GR
    Am J Gastroenterol; 2001 Jul; 96(7):1977-97. PubMed ID: 11467623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients.
    Ting PT; Koo JY
    Int J Dermatol; 2006 Jun; 45(6):689-92. PubMed ID: 16796629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E 3040.
    Drugs R D; 1999 Mar; 1(3):256-7. PubMed ID: 10566039
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation.
    Rouhani FN; Meitin CA; Kaler M; Miskinis-Hilligoss D; Stylianou M; Levine SJ
    Respir Med; 2005 Sep; 99(9):1175-82. PubMed ID: 16085220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acemannan. CARN 1000, CARN 750, polymannoacetate, Aliminase, Alovex, Carrisyn.
    Drugs R D; 1999 Mar; 1(3):251-2. PubMed ID: 10566037
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with an anti-TNFalpha in rheumatology].
    Goupille P
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 2):4S10-4S12. PubMed ID: 16335347
    [No Abstract]   [Full Text] [Related]  

  • 19. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etanercept (Enbrel) for the treatment of moderate to severe plaque type psoriasis].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2006 Mar; 61(3):201-5. PubMed ID: 16681009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.